Gamma-Glutamyltransferase: A Predictive Biomarker of Cellular Antioxidant Inadequacy and Disease Risk

Disease Markers

Volumn 2015, Issue , 2015, Pages

  Koenig, Gerald ^a,b   Seneff, Stephanie ^c  

^a Health e Iron   (United States)

^b Iron Disorders Institute   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; BIOLOGICAL MARKER; FERRITIN; GAMMA GLUTAMYLTRANSFERASE; IRON; GAMMA-GLUTAMYLTRANSFERASE, HUMAN;

ALBUMINURIA; ARTERIAL STIFFNESS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; ENVIRONMENTAL EXPOSURE; ETHNIC DIFFERENCE; FERRITIN BLOOD LEVEL; HEART FAILURE; HUMAN; INSULIN RESISTANCE; INSURANCE; KOREA; METABOLIC SYNDROME X; NEOPLASM; NITROSATIVE STRESS; OBESITY; OXIDATIVE STRESS; PREGNANCY DIABETES MELLITUS; PREHYPERTENSION; PRIORITY JOURNAL; REVIEW; VIRUS HEPATITIS; BLOOD; DIABETES MELLITUS; RENAL INSUFFICIENCY, CHRONIC;

BIOMARKERS; DIABETES MELLITUS; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; METABOLIC SYNDROME X; OXIDATIVE STRESS; RENAL INSUFFICIENCY, CHRONIC;

EID: 84946080000     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.1155/2015/818570     Document Type: Review

References (103)

1. J. B. Whitfield, "Gamma glutamyl transferase," Critical Reviews in Clinical Laboratory Sciences, vol. 38, no. 4, pp. 263-355, 2001.
2. A public service on clinical lab testing from the laboratory professionals who do the testing, Internet description of GGT provided by Lab Tests Online, 2015, https://labtestsonline.org/understanding/analytes/ggt/tab/test/.
3. S. Wickham, M. B. West, P. F. Cook, and M. H. Hanigan, "Gamma-glutamyl compounds: substrate specificity of gammaglutamyl transpeptidase enzymes," Analytical Biochemistry, vol. 414, no. 2, pp. 208-214, 2011.
4. A. Corti, T. L. Duarte, C. Giommarelli et al., "Membrane gamma-glutamyl transferase activity promotes iron-dependent oxidative DNA damage in melanoma cells," Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 669, no. 1-2, pp. 112-121, 2009.
5. H. Milnerowicz, R. Bukowski, M. Jabłonowska, M. ͆ciskalska, and S. Milnerowicz, "The antioxidant profiles, lysosomal and membrane enzymes activity in patients with acute pancreatitis," Mediators of Inflammation, vol. 2014, Article ID376518, 9 pages, 2014.
6. H. Aberkane, J.-F. Stoltz, M.-M. Galteau, and M. Wellman, "Erythrocytes as targets for gamma-glutamyltranspeptidase initiated pro-oxidant reaction," European Journal of Haematology, vol. 68, no. 5, pp. 262-271, 2002.
7. G. B. Stefano and R. M. Kream, "Nitric oxide regulation of mitochondrial processes: commonality in medical disorders," Annals of Transplantation, vol. 20, pp. 402-407, 2015.
8. M. Sreeram, A. N. Suryakar, and N. H. Dani, "Is gammaglutamyl transpeptidase a biomarker for oxidative stress in periodontitis?" Journal of Indian Society of Periodontology, vol. 19, no. 2, pp. 150-154, 2015.
9. D. S. Lee, J. C. Evans, S. J. Robins et al., "Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, andmortality risk: the Framingham Heart study," Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 1, pp. 127-133, 2007.
10. R. Dhingra, P. Gona, T. J. Wang, C. S. Fox, R. B. Dagostino, and R. S. Vasan, "Serum γ-glutamyl transferase and risk of heart failure in the community," Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 30, no. 9, pp. 1855-1860, 2010.
11. D.-H. Lee, L. M. Steffen, and D. R. Jacobs Jr., "Association between serum γ-glutamyltransferase and dietary factors: the Coronary Artery Risk Development in Young Adults (CARDIA) Study," American Journal of Clinical Nutrition, vol. 79, no. 4, pp. 600-605, 2004.
12. J. Montonen, H. Boeing, A. Fritsche et al., "Consumption of red meat and whole-grain bread in relation to biomarkers of obesity, inflammation, glucose metabolism and oxidative stress," European Journal of Nutrition, vol. 52, no. 1, pp. 337-345, 2013.
13. N.M. Pham, W. Zhenjie, M. Morita et al., "Combined effects of coffee consumption and serumγ-glutamyltransferase on serum C-reactive protein in middle-aged and elderly Japanese men and women," Clinical Chemistry and Laboratory Medicine, vol. 49, no. 10, pp. 1661-1667, 2011.
14. M. Sartori, S. Andorno, A. Rossini et al., "Phlebotomy improves histology in chronic hepatitis C males withmild iron overload," World Journal of Gastroenterology, vol. 16, no. 5, pp. 596-602, 2010.
15. L. Kazemi-Shirazi, G. Endler, S. Winkler, T. Schickbauer, O. Wagner, and C. Marsik, "Gamma glutamyltransferase and longtermsurvival: is it just the liver?" Clinical Chemistry, vol. 53, no. 5, pp. 940-946, 2007.
16. D.-H. Lee, K. Silventoinen, G. Hu et al., "Serum gamma-glutamyltransferase predicts non-fatal myocardial infarction and fatal coronary heart disease among 28 838 middle-aged men and women," European Heart Journal, vol. 27, no. 18, pp. 2170-2176, 2006.
17. C. E. Ruhl and J. E. Everhart, "Elevated serum alanine aminotransferase and γ-glutamyltransferase and mortality in the United States population," Gastroenterology, vol. 136, no. 2, pp. 477-485, 2009.
18. E. Ruttmann, L. J. Brant, H. Concin, G. Diem, K. Rapp, and H. Ulmer, "γ-Glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163 944 Austrian adults," Circulation, vol. 112, no. 14, pp. 2130-2137, 2005.
19. M. Postorino, C. Marino, G. Tripepi, and C. Zoccali, "Gamma-glutamyltransferase in ESRD as a predictor of all-cause and cardiovascular mortality: another facet of oxidative stress burden," Kidney International, vol. 74, no. 111, pp. S64-S66, 2008.
20. J. Himmelfarb, P. Stenvinkel, T. A. Ikizler, and R. M. Hakim, "The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia," Kidney International, vol. 62, no. 5, pp. 1524-1538, 2002.
21. G. R. Buettner and B.A. Jurkiewicz, "Catalytic metals, ascorbate and free radicals: combinations to avoid," Radiation Research, vol. 145, no. 5, pp. 532-541, 1996.
22. A. M. Strasak, K. Rapp, L. J. Brant et al., "Association of γ- glutamyltransferase and risk of cancer incidence in men: a prospective study," Cancer Research, vol. 68, no. 10, pp. 3970-3977, 2008.
23. A. M. Strasak, R. M. Pfeiffer, J. Klenk et al., "Prospective study of the association of gamma-glutamyltransferase with cancer incidence in women," International Journal of Cancer, vol. 123, no. 8, pp. 1902-1906, 2008.
24. Y. Mok, D. K. Son, Y. Y. Duk, S. H. Jee, and J. M. Samet, "γ-Glutamyltransferase and cancer risk: the Korean cancer prevention study," International Journal of Cance, 2015.
25. G. Lum, "Gamma-glutamyl transpeptidase in cancer diagnosis," Annals of Clinical & Laboratory Science, vol. 4, no. 1, pp. 13-18, 1974.
26. J.-S. Lim, J.-H. Yang, B.-Y. Chun, S. Kam, D. R. Jacobs Jr., and D.-H. Lee, "Is serum γ-glutamyltransferase inversely associated with serum antioxidants as a marker of oxidative stress?" Free Radical Biology and Medicine, vol. 37, no. 7, pp. 1018-1023, 2004.
27. D.-H. Lee, M. D. Gross, and D. R. Jacobs Jr., "Association of serumcarotenoids and tocopherols with γ-glutamyltransferase: the Cardiovascular Risk Development in Young Adults (CARDIA) study," Clinical Chemistry, vol. 50, no. 3, pp. 582-588, 2004.
28. D.-H. Lee and D. R. Jacobs Jr., "Association between serum gamma-glutamyltransferase and C-reactive protein," Atherosclerosis, vol. 178, no. 2, pp. 327-330, 2005.
29. K.-N. Kim, K.-M. Kim, D.-J. Lee, and N.-S. Joo, "Serum gamma-glutamyltransferase concentration correlates with Framingham risk score in Koreans," Journal of Korean Medical Science, vol. 26, no. 10, pp. 1305-1309, 2011.
30. A. I. Atar, O. C. Yilmaz, K. Akin, Y. Selcoki, O. Er, and B. Eryonucu, "Association between gamma-glutamyltransferase and coronary artery calcification," International Journal of Cardiology, vol. 167, no. 4, pp. 1264-1267, 2013.
31. W. Lee, J.-H. Ryoo, B. S. Suh, J. Lee, and J. Kim, "Association of coronary artery calcification and serum gamma-glutamyl transferase in Korean," Atherosclerosis, vol. 226, no. 1, pp. 269-274, 2013.
32. O. Celik, H. A. Cakmak, S. Satilmis et al., "The relationship between gamma-glutamyl transferase levels and coronary plaque burdens and plaque structures in young adults with coronary atherosclerosis," Clinical Cardiology, vol. 37, no. 9, pp. 552-557, 2014.
33. D.-H. Lee and D. R. Jacobs, "Is serum γ-glutamyltransferase an exposure marker of xenobiotics? Empirical evidence with polycylic aromatic hydrocarbon," Clinical Chemistry and Laboratory Medicine, vol. 47, no. 7, pp. 860-862, 2009.
34. D.-H. Lee, M. W. Steffes, and D. R. Jacobs Jr., "Can persistent organic pollutants explain the association between serum γ- glutamyltransferase and type 2 diabetes?" Diabetologia, vol. 51, no. 3, pp. 402-407, 2008.
35. S. K. Venn-Watson, C. Parry, M. Baird et al., "Increased dietary intake of saturated fatty acid heptadecanoic acid (C17:0) associated with decreasing ferritin and alleviated metabolic syndrome in dolphins," PLOS ONE, vol. 10, no. 7, Article ID e0132117, 2015.
36. Science Daily, 2015, http://www.sciencedaily.com/releases/2015/07/150722144627.htm.
37. S. P. Johnson, S. K. Venn-Watson, S. E. Cassle, C. R. Smith, E. D. Jensen, and S. H. Ridgway, "Use of phlebotomy treatment in Atlantic bottlenose dolphins with iron overload," Journal of the American Veterinary Medical Association, vol. 235, no. 2, pp. 194-200, 2009.
38. L. Valenti, A. L. Fracanzani, P. Dongiovanni et al., "A randomized trial of iron depletion in patients with nonalcoholic fatty liver disease and hyperferritinemia," World Journal of Gastroenterology, vol. 20, no. 11, pp. 3002-3010, 2014.
39. B. Jenkins, J. A. West, and A. Koulman, "A review of oddchain fatty acid metabolism and the role of pentadecanoic acid (C15:0) and heptadecanoic acid (C17:0) in health and disease," Molecules, vol. 20, no. 2, pp. 2425-2444, 2015.
40. M. A. Pereira, D. R. Jacobs Jr., L. Van Horn, M. L. Slattery, A. I. Kartashov, and D. S. Ludwig, "Dairy consumption, obesity, and the insulin resistance syndrome in young adults: the CARDIA study," The Journal of the American Medical Association, vol. 287, no. 16, pp. 2081-2089, 2002.
41. M. Y. Abdalla, M. Fawzi, S. R. Al-Maloul, N. El-Banna, R. F. Tayyem, and I. M. Ahmad, "Increased oxidative stress and iron overload in Jordanian β-thalassemic children," Hemoglobin, vol. 35, no. 1, pp. 67-79, 2011.
42. H.F. J. Hendriks, E. J. Brink, G.W. Meijer, H.M.G. Princen, and F. Y. Ntanios, "Safety of long-term consumption of plant sterol esters-enriched spread," European Journal of Clinical Nutrition, vol. 57, no. 5, pp. 681-692, 2003.
43. D.-H. Lee, J.-S. Lim, K. Song, Y. Boo, and D. R. Jacobs Jr., "Graded associations of blood lead and urinary cadmium concentrations with oxidative-stress-related markers in the U.S. population: results from the third National Health and Nutrition Examination Survey," Environmental Health Perspectives, vol. 114, no. 3, pp. 350-354, 2006.
44. A.K. McElroy, B. R. Erickson, T. D. Flietstra et al., "Ebola hemorrhagic fever: novel biomarker correlates of clinical outcome," The Journal of Infectious Diseases, vol. 210, no. 4, pp. 558-566, 2014.
45. T.K. Warren, J. C. Trefry, S. T. Marko et al., "Euthanasia assessment in ebola virus infected nonhuman primates," Viruses, vol. 6, no. 11, pp. 4666-4682, 2014.
46. F. A. Badria, A. S. Ibrahim, A. F. Badria, A.A. Elmarakby, and G. Li Volti, "Curcumin attenuates iron accumulation and oxidative stress in the liver and spleen of chronic iron-overloaded rats," PLOS ONE, vol. 10, no. 7, Article IDe0134156, 2015.
47. N. Kamalakkannan, R. Rukkumani, P. S. Varma, P. Viswanathan, K. N. Rajasekharan, and V. P. Menon, "Comparative effects of curcumin and an analogue of curcumin in carbon tetrachloride-induced hepatotoxicity in rats," Basic & Clinical Pharmacology & Toxicology, vol. 97, no. 1, pp. 15-21, 2005.
48. P. F. Baillie-Hamilton, "Chemical toxins: a hypothesis to explain the global obesity epidemic," The Journal of Alternative and Complementary Medicine, vol. 8, no. 2, pp. 185-192, 2002.
49. Y. J. Suh, S. K. Park, J.-M. Choi, and J.-H. Ryoo, "The clinical importance of serum γ-glutamyltransferase level as an early predictor of obesity development in Korean men," Atherosclerosis, vol. 227, no. 2, pp. 437-441, 2013.
50. S. Alam, S. M. Noor-E-Alam, Z. R. Chowdhury, M. Alam, and J. Kabir, "Nonalcoholic steatohepatitis in nonalcoholic fatty liver disease patients of Bangladesh," World Journal of Hepatology, vol. 5, no. 5, pp. 281-287, 2013.
51. S. K. Park, W. J. Choi, C.-M. Oh, J. Kim, H. Shin, and J.-H. Ryoo, "Association between serum ferritin levels and the incidence of obesity in Korean men: a prospective cohort study," Endocrine Journal, vol. 61, no. 3, pp. 215-224, 2014.
52. S. K. Park, J.-H. Ryoo, M.-G. Kim, and J.-Y. Shin, "Association of serum ferritin and the development of metabolic syndrome in middle-aged Koreanmen: a 5-year follow-up study," Diabetes Care, vol. 35, no. 12, pp. 2521-2526, 2012.
53. B.-S. Suh, "The association between serum gamma-glutamyltransferase within normal levels and metabolic syndrome in office workers: a 4-year follow-up study," Korean Journal of Family Medicine, vol. 33, no. 1, pp. 51-58, 2012.
54. G. Targher, M. Franchini, M. Montagnana, and G. Lippi, "The role of iron in diabetes and its complications: reponse to Swaminathan et al," Diabetes Care, vol. 30, no. 12, article e132, 2007.
55. S. Swaminathan, V. A. Fonseca, M. G. Alam, and S.V. Shah, "The role of iron in diabetes and its complications," Diabetes Care, vol. 30, no. 7, pp. 1926-1933, 2007.
56. D. Wei, T. Chen, J. Li et al., "Association of serum gammaglutamyl transferase and ferritin with the metabolic syndrome," Journal of Diabetes Research, vol. 2015, Article ID 741731, 10 pages, 2015.
57. S.M. Grundy, J. I. Cleeman, S. R. Daniels et al., "Diagnosis and management of the metabolic syndrome: an American Heart Association/NationalHeart, Lung, and Blood Institute scientific statement," Circulation, vol. 112, no. 17, pp. 2735-2752, 2005.
58. H. Chun, S. K. Park, and J.-H. Ryoo, "Association of serum γ-glutamyltransferase level and incident prehypertension in Korean men," Journal of Korean medical science, vol. 28, no. 11, pp. 1603-1608, 2013.
59. J.-H. Ryoo, C.-M. Oh, H. S. Kim, S. K. Park, and J.-M. Choi, "Clinical association between serum γ-glutamyltransferase levels and the development of insulin resistance in Korean men: a 5-year follow-up study," Diabetic Medicine, vol. 31, no. 4, pp. 455-461, 2014.
60. S. B. Sridhar, F. Xu, J. Darbinian, C. P. Quesenberry, A. Ferrara, and M. M. Hedderson, "Pregravid liver enzyme levels and risk of gestational diabetesmellitus during a subsequent pregnancy," Diabetes Care, vol. 37, no. 7, pp. 1878-1884, 2014.
61. T. Zhuang, H. Han, and Z. Yang, "Iron, oxidative stress and gestational diabetes," Nutrients, vol. 6, no. 9, pp. 3968-3980, 2014.
62. D.-H. Lee, R. Blomhoff, and D. R. Jacobs Jr., "Is serumgamma glutamyltransferase a marker of oxidative stress?" Free Radical Research, vol. 38, no. 6, pp. 535-539, 2004.
63. S. Zein, S. Rachidi, S. Awada et al., "High iron level in early pregnancy increased glucose intolerance," Journal of Trace Elements in Medicine and Biology, vol. 30, pp. 220-225, 2015.
64. P. Javadian, S. Alimohamadi, M. H. Gharedaghi, and S. Hantoushzadeh, "Gestational diabetes mellitus and iron supplement; effects on pregnancy outcome," Acta Medica Iranica, vol. 52, no. 5, pp. 385-389, 2014.
65. F. N. Amiri, Z. Basirat, S. Omidvar, M. Sharbatdaran, K. H. Tilaki, and M. Pouramir, "Comparison of the serum iron, ferritin levels and total iron-binding capacity between pregnant women with and without gestational diabetes," Journal of Natural Science, Biology and Medicine, vol. 4, no. 2, pp. 302-305, 2013.
66. M. Sartori, S. Andorno, A. Rossini et al., "A case-control histological study on the effects of phlebotomy in patients with chronic hepatitis C," European Journal of Gastroenterology and Hepatology, vol. 23, no. 12, pp. 1178-1184, 2011.
67. R. Rukkumani, K. Aruna, P. S. Varma, K. N. Rajasekaran, and V. P. Menon, "Comparative effects of curcumin and an analog of curcumin on alcohol and PUFA induced oxidative stress," Journal of Pharmacy and Pharmaceutical Sciences, vol. 7, no. 2, pp. 274-283, 2004.
68. S. Minear, A. F. O'Donnell, A. Ballew et al., "Curcumin inhibits growth of saccharomyces cerevisiae through iron chelation," Eukaryotic Cell, vol. 10, no. 11, pp. 1574-1581, 2011.
69. S. Chuengsamarn, S. Rattanamongkolgul, R. Luechapudiporn, C. Phisalaphong, and S. Jirawatnotai, "Curcumin extract for prevention of type 2 diabetes," Diabetes Care, vol. 35, no. 11, pp. 2121-2127, 2012.
70. J. Palmier, A. Dixon, and B. Lanzarth, Leading Contributors to Mortality Risk in Life Insurance Applicants, Smalltalk Issue 38, Society of Actuaries, Schaumburg, Ill, USA, 2012.
71. J. Palmier and B. J. Lanzrath, "Laboratory and biometric predictors of cancer-relatedmortality in an insured population," Journal of Insurance Medicine, vol. 43, no. 3, pp. 162-168, 2012.
72. E. E. Calle, C. Rodriguez, K. Walker-Thurmond, and M. J. Thun, "Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults," The New England Journal of Medicine, vol. 348, no. 17, pp. 1625-1638, 2003.
73. M. C. Gonzalez, C. A. Pastore, S. P. Orlandi, and S. B. Heymsfield, "Obesity paradox in cancer: new insights provided by body composition," The American Journal of Clinical Nutrition, vol. 99, no. 5, pp. 999-1005, 2014.
74. W. Nie, Y. Zhang, S. H. Jee, K. J. Jung, B. Li, and Q. Xiu, "Obesity survival paradox in pneumonia: a meta-analysis," BMC Medicine, vol. 12, no. 1, article 61, 2014.
75. Y. Pan and R. T. Jackson, "Insights into the ethnic differences in serum ferritin between black and white US adult men," American Journal of Human Biology, vol. 20, no. 4, pp. 406-416, 2008.
76. L.R. Zacharski, D. L. Ornstein, S. Woloshin, and L.M. Schwartz, "Association of age, sex, and race with body iron stores in adults: analysis of NHANES III data," American Heart Journal, vol. 140, no. 1, pp. 98-104, 2000.
77. J. L. Sullivan, "Iron and sex difference in heart disease risk," The Lancet, vol. 317, no. 8233, pp. 1293-1294, 1981.
78. J. L. Sullivan, "Stored iron and ischemic heart disease: empirical support for a new paradigm," Circulation, vol. 86, no. 3, pp. 1036-1037, 1992.
79. D. A. Patel, S. R. Srinivasan, J.-H. Xu, W. Chen, and G. S. Berenson, "Persistent elevation of liver function enzymeswithin the reference range is associated with increased cardiovascular risk in young adults: the Bogalusa Heart Study," Metabolism: Clinical and Experimental, vol. 56, no. 6, pp. 792-798, 2007.
80. K. E. Brown, M. T. Kinter, T. D. Oberley et al., "Enhanced γ- glutamyl transpeptidase expression and selective loss of CuZn superoxide dismutase in hepatic iron overload," Free Radical Biology and Medicine, vol. 24, no. 4, pp. 545-555, 1998.
81. A. Paolicchi, S. Dominici, L. Pieri, E. Maellaro, and A. Pompella, "Glutathione catabolism as a signaling mechanism," Biochemical Pharmacology, vol. 64, no. 5, pp. 1027-1035, 2002.
82. V. M. Moyo, E. Mvundura, H. Khumalo et al., "Serum ferritin concentrations in Africans with low dietary iron," Annals of Hematology, vol. 88, no. 11, pp. 1131-1136, 2009.
83. R. W. Lambrecht, R. K. Sterling, D. Naishadham et al., "Iron levels in hepatocytes and portal tract cells predict progression and outcomes of patients with advanced chronic hepatitis C," Gastroenterology, vol. 140, no. 5, pp. 1490-1500, 2011.
84. H. L. Bonkovsky, D. Naishadham, R. W. Lambrecht et al., "Roles of iron and HFE mutations on severity and response to therapy during retreatment of advanced chronic hepatitis C," Gastroenterology, vol. 131, no. 5, pp. 1440-1451, 2006.
85. J. E. Everhart and E. C. Wright, "Association of γ-glutamyl transferase (GGT) activitywith treatment and clinical outcomes in chronic hepatitis C (HCV)," Hepatology, vol. 57, no. 5, pp. 1725-1733, 2013.
86. M. Lemoine, Y. Shimakawa, S. Nayagam et al., "The gammaglutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa," Gut, 2015.
87. World Health Organization, Guidelines for the Prevention, Care and Treatment of Persons with Chronic Hepatitis B Infection, WHO, 2015, http://apps.who.int/iris/bitstream/10665/154590/1/9789241549059 eng.pdf?ua=1&ua=1.
88. A. T. Eminler, K. Irak, T. Ayyildiz et al., "The relation between liver histopathology and GGT levels in viral hepatitis: more important in hepatitis B," The Turkish Journal of Gastroenterology, vol. 25, no. 4, pp. 411-415, 2014.
89. R. P. Myers, M.-H. Tainturier, V. Ratziu et al., "Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B," Journal of Hepatology, vol. 39, no. 2, pp. 222-230, 2003.
90. R. T. Acton, J. C. Barton, L. V. Passmore et al., "Relationships of serum ferritin, transferrin saturation, and HFE mutations and self-reported diabetes in the Hemochromatosis and Iron Overload Screening (HEIRS) study," Diabetes Care, vol. 29, no. 9, pp. 2084-2089, 2006.
91. M. E. Olesnevich, M. F. Kuczmarski, M. Mason, C. Fang, A. B. Zonderman, and M. K. Evans, "Serum ferritin levels associated with increased risk for developing CHD in a low-income urban population," Public Health Nutrition, vol. 15, no. 7, pp. 1291-1298, 2012.
92. M. E. Olesnevich, M. F. Kuczmarski, M. Mason, C. Fang, A. B. Zonderman, and M. K. Evans, "Serum ferritin levels associated with increased risk for developing CHD in a low-income urban population-corrigendum," Public Health Nutrition, vol. 15, no. 6, article 1138, 2012.
93. Y. Zhan, Z. Tang, and J. Yu, "Serum ferritin, diabetes, diabetes control, and insulin resistance," Acta Diabetologica, vol. 51, no. 6, pp. 991-998, 2014.
94. L. Sun, O. H. Franco, F. B. Hu et al., "Ferritin concentrations, metabolic syndrome, and type 2 diabetes in middle-aged and elderly Chinese," The Journal of Clinical Endocrinology & Metabolism, vol. 93, no. 12, pp. 4690-4696, 2008.
95. WHO, Serum Ferritin Concentrations for the Assessment of Iron Status and Iron Deficiency in Populations. Vitamin and Mineral Nutrition Information System, WHO/NMH/NHD/MNM/11.2, World Health Organization, Geneva, Switzerland, 2011, http://www.who.int/vmnis/indicators/serum ferritin.pdf.
96. S. Ryu, Y. Chang, D.-I. Kim, W. S. Kim, and B.-S. Suh, "γ- glutamyltransferase as a predictor of chronic kidney disease in nonhypertensive and nondiabetic Korean men," Clinical Chemistry, vol. 53, no. 1, pp. 71-77, 2007.
97. D.-H. Lee, M.-H. Ha, S. Kam et al., "A strong secular trend in serum gamma-glutamyltransferase from 1996 to 2003 among South Koreanmen," American Journal of Epidemiology, vol. 163, no. 1, pp. 57-65, 2006.
98. W.-Y. Park, S.-H. Kim, Y. O. Kim et al., "Serum gamma-glutamyltransferase levels predict mortality in patients with peritoneal dialysis," Medicine, vol. 94, no. 31, Article ID e1249, 2015.
99. K. Sun, F. Li, D. Lin et al., "Serum gamma-glutamyltransferase is associated with albuminuria: a population-based study," PLoS ONE, vol. 9, no. 12, Article IDe114970, 2014.
100. I. J. Perry, S. G. Wannamethee, and A. G. Shaper, "Prospective study of serum γ-glutamyltransferase and risk of NIDDM," Diabetes Care, vol. 21, no. 5, pp. 732-737, 1998.
101. 2: the role of γ-glutamyltransferase. Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR)," Diabetologia, vol. 53, no. 2, pp. 247-253, 2010.
102. S. Teppala, A. Shankar, J. Li, T. Y. Wong, and A. Ducatman, "Association between serum γ-glutamyltransferase and chronic kidney disease among us adults," Kidney and Blood Pressure Research, vol. 33, no. 1, pp. 1-6, 2010.
103. Y. Wang and M. A. Beydoun, "The obesity epidemic in the United States-gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and metaregression analysis," Epidemiologic Reviews, vol. 29, no. 1, pp. 6-28, 2007.